InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Samuel George A. III. Officer active across 1 company, notably Lineage Cell Therapeutics, Inc.. Aggregated, 4 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €9k. History available since 26 November 2024. The latest transaction was disclosed on 26 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations